ARWR
Stock·OPENNYSE/NASDAQArrowhead Pharmaceuticals — Arrowhead Pharmaceuticals develops RNA interference medicines for cardiometabolic, pulmonary, liver, and other diseases.
Price
85.50
24H
—
Volume 24h
$76.24K
OI (USD)
$73.9K
Market Cap
$11.97B
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
 | ARWRSTOCK_USDT | 85.50 | 85.00 | +58.8 bps | --:--:--+0.0125%(+13.69% ann) | $76.24K | 100.0% | $73.9K | 47d |